LPA1 has been implicated in cancer invasion, lung fibrosis, autoimmune disorders, hydrocephalus, and neuropathic pain, and LPA1 antagonists have been under development for treating autoimmune diseases and cancers [68, 69]. This evidence concerns the gene LPAR1 and cancer.